Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA01 CICLOSPORINUM CAPS. MOI 100 mg

EQUORAL(R) 100 mg 100 mg IVAX - PHARMACEUTICALS

S.R.O.
L04AA01 CICLOSPORINUM SOL. ORALA 100 mg/ml

EQUORAL(R) 100 mg/ml IVAX - PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 25 mg

CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG

EQUORAL(R) 25 mg 25 mg IVAX - PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 50 mg

CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG

EQUORAL(R) 50 mg 50 mg IVAX - PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________

______________________________________________________________________________

| 1012 |L04AA06| MYCOPHENOLATUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 180 mg

MYFORTIC 180 mg 180 mg NOVARTIS PHARMA GMBH
L04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALA 1 g/5 ml

CELLCEPT 1 mg/5 ml 1 g/5 ml ROCHE REGISTRATION LTD.

L04AA06 MYCOPHENOLATUM CAPS. 250 mg

CELLCEPT 250 mg 250 mg ROCHE REGISTRATION LTD.

MYFENAX 250 mg 250 mg TEVA PHARMA BV
L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 360 mg

MYFORTIC 360 mg 360 mg NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM CAPS. 500 mg

MYFENAX 500 mg 500 mg TEVA PHARMA BV

L04AA06 MYCOPHENOLATUM COMPR. FILM. 500 mg

CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD.

L04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. 500 mg

SOL. PERF.

CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD.

________________________________________________________________________________

______________________________________________________________________________

| 1013 |L04AA09| BASILIXIMABUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA09 BASILIXIMABUM LIOF. + SOLV. PT. SOL. 20 mg

INJ./PERF.

SIMULECT 20 mg 20 mg NOVARTIS EUROPHARM LTD.

________________________________________________________________________________
______________________________________________________________________________

| 1014 |L04AX01| AZATHIOPRINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg

IMURAN(R) 50 mg THE WELLCOME FOUNDATION

LTD.

________________________________________________________________________________
______________________________________________________________________________

| 1015 |N02AX02| TRAMADOLUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Durere severă, care nu răspunde la analgezice